Noninvasive monitoring of local drug release in a rabbit radiofrequency (RF) ablation model using X-ray computed tomography

Agata Szymanski-Exner, Nicholas T. Stowe, Roee S. Lazebnik, Kyle Salem, David L. Wilson, John R. Haaga, Jinming Gao

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

In this study, X-ray computed tomography (CT) was utilized as a noninvasive method to directly examine local drug release kinetics in livers before and following radiofrequency thermal ablation. Iohexol, a CT contrast agent, was used as a drug-mimicking molecule. Release of iohexol in healthy and ablated rabbit livers over 48 h was quantified and correlated with the release profiles from phosphate-buffered saline (PBS) in vitro. The results show that iohexol release in ablated livers is significantly slower than both release in normal livers and in vitro. The time at which 50% of the drug was released (t1/2) into ablated liver (20.6±5.9 h) was 1.7 times longer than in normal liver (12.1±5.4 h) and approximately two times longer than that in PBS (10.1±1.2 h). The slower release in ablated livers is a result of severe tissue damage inflicted by thermal ablation, as supported by histological examination. This data suggests that a noninvasive imaging method provides a superior measurement over in vitro release studies in accurately quantifying the local release kinetics of an agent in an altered physiological system in vivo. Because the development of a successful local drug therapy is dependent on the understanding of the agent release kinetics at the implantation site, the noninvasive data may be indispensable in effectively predicting the implant behavior in a physiological system.

Original languageEnglish (US)
Pages (from-to)415-425
Number of pages11
JournalJournal of Controlled Release
Volume83
Issue number3
DOIs
StatePublished - Oct 30 2002

Fingerprint

X Ray Computed Tomography
Rabbits
Iohexol
Liver
Hot Temperature
Phosphates
Drug Liberation
Pharmaceutical Preparations
Contrast Media
Pharmacokinetics
Tomography
Drug Therapy
In Vitro Techniques

Keywords

  • Iohexol
  • Local drug delivery
  • Pharmacokinetics
  • Rabbit model
  • Radiofrequency ablation
  • X-ray CT

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Noninvasive monitoring of local drug release in a rabbit radiofrequency (RF) ablation model using X-ray computed tomography. / Szymanski-Exner, Agata; Stowe, Nicholas T.; Lazebnik, Roee S.; Salem, Kyle; Wilson, David L.; Haaga, John R.; Gao, Jinming.

In: Journal of Controlled Release, Vol. 83, No. 3, 30.10.2002, p. 415-425.

Research output: Contribution to journalArticle

Szymanski-Exner, Agata ; Stowe, Nicholas T. ; Lazebnik, Roee S. ; Salem, Kyle ; Wilson, David L. ; Haaga, John R. ; Gao, Jinming. / Noninvasive monitoring of local drug release in a rabbit radiofrequency (RF) ablation model using X-ray computed tomography. In: Journal of Controlled Release. 2002 ; Vol. 83, No. 3. pp. 415-425.
@article{584c754b8d82491ba3aaadf5185f4e7f,
title = "Noninvasive monitoring of local drug release in a rabbit radiofrequency (RF) ablation model using X-ray computed tomography",
abstract = "In this study, X-ray computed tomography (CT) was utilized as a noninvasive method to directly examine local drug release kinetics in livers before and following radiofrequency thermal ablation. Iohexol, a CT contrast agent, was used as a drug-mimicking molecule. Release of iohexol in healthy and ablated rabbit livers over 48 h was quantified and correlated with the release profiles from phosphate-buffered saline (PBS) in vitro. The results show that iohexol release in ablated livers is significantly slower than both release in normal livers and in vitro. The time at which 50{\%} of the drug was released (t1/2) into ablated liver (20.6±5.9 h) was 1.7 times longer than in normal liver (12.1±5.4 h) and approximately two times longer than that in PBS (10.1±1.2 h). The slower release in ablated livers is a result of severe tissue damage inflicted by thermal ablation, as supported by histological examination. This data suggests that a noninvasive imaging method provides a superior measurement over in vitro release studies in accurately quantifying the local release kinetics of an agent in an altered physiological system in vivo. Because the development of a successful local drug therapy is dependent on the understanding of the agent release kinetics at the implantation site, the noninvasive data may be indispensable in effectively predicting the implant behavior in a physiological system.",
keywords = "Iohexol, Local drug delivery, Pharmacokinetics, Rabbit model, Radiofrequency ablation, X-ray CT",
author = "Agata Szymanski-Exner and Stowe, {Nicholas T.} and Lazebnik, {Roee S.} and Kyle Salem and Wilson, {David L.} and Haaga, {John R.} and Jinming Gao",
year = "2002",
month = "10",
day = "30",
doi = "10.1016/S0168-3659(02)00216-X",
language = "English (US)",
volume = "83",
pages = "415--425",
journal = "Journal of Controlled Release",
issn = "0168-3659",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Noninvasive monitoring of local drug release in a rabbit radiofrequency (RF) ablation model using X-ray computed tomography

AU - Szymanski-Exner, Agata

AU - Stowe, Nicholas T.

AU - Lazebnik, Roee S.

AU - Salem, Kyle

AU - Wilson, David L.

AU - Haaga, John R.

AU - Gao, Jinming

PY - 2002/10/30

Y1 - 2002/10/30

N2 - In this study, X-ray computed tomography (CT) was utilized as a noninvasive method to directly examine local drug release kinetics in livers before and following radiofrequency thermal ablation. Iohexol, a CT contrast agent, was used as a drug-mimicking molecule. Release of iohexol in healthy and ablated rabbit livers over 48 h was quantified and correlated with the release profiles from phosphate-buffered saline (PBS) in vitro. The results show that iohexol release in ablated livers is significantly slower than both release in normal livers and in vitro. The time at which 50% of the drug was released (t1/2) into ablated liver (20.6±5.9 h) was 1.7 times longer than in normal liver (12.1±5.4 h) and approximately two times longer than that in PBS (10.1±1.2 h). The slower release in ablated livers is a result of severe tissue damage inflicted by thermal ablation, as supported by histological examination. This data suggests that a noninvasive imaging method provides a superior measurement over in vitro release studies in accurately quantifying the local release kinetics of an agent in an altered physiological system in vivo. Because the development of a successful local drug therapy is dependent on the understanding of the agent release kinetics at the implantation site, the noninvasive data may be indispensable in effectively predicting the implant behavior in a physiological system.

AB - In this study, X-ray computed tomography (CT) was utilized as a noninvasive method to directly examine local drug release kinetics in livers before and following radiofrequency thermal ablation. Iohexol, a CT contrast agent, was used as a drug-mimicking molecule. Release of iohexol in healthy and ablated rabbit livers over 48 h was quantified and correlated with the release profiles from phosphate-buffered saline (PBS) in vitro. The results show that iohexol release in ablated livers is significantly slower than both release in normal livers and in vitro. The time at which 50% of the drug was released (t1/2) into ablated liver (20.6±5.9 h) was 1.7 times longer than in normal liver (12.1±5.4 h) and approximately two times longer than that in PBS (10.1±1.2 h). The slower release in ablated livers is a result of severe tissue damage inflicted by thermal ablation, as supported by histological examination. This data suggests that a noninvasive imaging method provides a superior measurement over in vitro release studies in accurately quantifying the local release kinetics of an agent in an altered physiological system in vivo. Because the development of a successful local drug therapy is dependent on the understanding of the agent release kinetics at the implantation site, the noninvasive data may be indispensable in effectively predicting the implant behavior in a physiological system.

KW - Iohexol

KW - Local drug delivery

KW - Pharmacokinetics

KW - Rabbit model

KW - Radiofrequency ablation

KW - X-ray CT

UR - http://www.scopus.com/inward/record.url?scp=0037202214&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037202214&partnerID=8YFLogxK

U2 - 10.1016/S0168-3659(02)00216-X

DO - 10.1016/S0168-3659(02)00216-X

M3 - Article

C2 - 12387949

AN - SCOPUS:0037202214

VL - 83

SP - 415

EP - 425

JO - Journal of Controlled Release

JF - Journal of Controlled Release

SN - 0168-3659

IS - 3

ER -